Increased Incidence of Tinnitus Following a Hyperthyroidism Diagnosis: A Population-Based Longitudinal Study
- PMID: 34803911
- PMCID: PMC8595298
- DOI: 10.3389/fendo.2021.741719
Increased Incidence of Tinnitus Following a Hyperthyroidism Diagnosis: A Population-Based Longitudinal Study
Abstract
Background: An association between thyroid disease and tinnitus has been described previously but further longitudinal, population-based studies are limited.
Objective: To investigate the incidence of tinnitus in patients with hyperthyroidism in a national sample, and to identify risk level and associated factors for tinnitus in hyperthyroidism patients.
Design: Retrospective cohort study. Patient data were collected from the Longitudinal Health Insurance Database (LHID 2000), which includes national claims data of patient expenditures for admissions or ambulatory care from 1996 to 2011.
Setting: Taiwan hospitals and clinics providing healthcare nationwide.
Participants: Patients aged 20 years and older with newly diagnosed hyperthyroidism (ICD-9-CM code 242) between 2000-2010 were selected as the study cohort. Hyperthyroidism patient cohort were identified from the LHID2000. Those with tinnitus history (ICD-9-CM code 388.3) before the index date (first hyperthyroidism diagnosis), younger than 20 years, and with incomplete demographic data were excluded. The non-hyperthyroidism cohort included patients with no history of hyperthyroidism and no documented tinnitus.
Main outcomes and measures: Incidence of tinnitus was the primary outcome. Baseline demographic factors and comorbidities possibly associated with tinnitus, including age, sex, and comorbidities of hearing loss, vertigo, insomnia and anxiety, were retrieved from the LHID 2000. Patients were followed until end of 2011.
Results: During the study period, 780 (4.9%) hyperthyroidism patients and 2007 (3.2%) non-hyperthyroidism controls developed tinnitus. Incidence rate of tinnitus in the hyperthyroidism cohort was significantly higher in hyperthyroidism cohort (7.86 vs. 5.05 per 1000 person-years) than that in non-hyperthyroidism cohort. A higher proportion of patients with hyperthyroidism had comorbid insomnia (45.1% vs. 30.9%) and anxiety (14.0% vs. 5.73%) than those without hyperthyroidism. After adjusting for age, gender and comorbidities (vertigo, insomnia, anxiety, hearing loss), hyperthyroidism patients had 1.38-fold higher risk of tinnitus (95% CI = 1.27-1.50) than those without hyperthyroidism.
Conclusions: This large population-based study suggests patients with diagnosed hyperthyroidism was more prone to develop tinnitus. Our findings suggest evaluation for comorbid vertigo, insomnia, anxiety and/or hearing loss may identify patients who are at high risk of developing tinnitus in patients with hyperthyroidism.
Keywords: cohort study; hyperthyroidism; incidence; national health insurance research database; risk factors; tinnitus.
Copyright © 2021 Wang, Chiu, Chen, Chang, Tyler, Rojas-Roncancio, Coelho, Mancini, Lin, Lin and Tsai.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Hypothyroidism and related comorbidities on the risks of developing tinnitus.Sci Rep. 2022 Mar 1;12(1):3401. doi: 10.1038/s41598-022-07457-0. Sci Rep. 2022. PMID: 35233053 Free PMC article.
-
Increased risk of tinnitus in patients with early-onset cataracts: a nationwide population-based case-control study.BMC Ophthalmol. 2020 Jun 16;20(1):230. doi: 10.1186/s12886-020-01497-8. BMC Ophthalmol. 2020. PMID: 32546219 Free PMC article.
-
Association of sudden sensorineural hearing loss with increased risk of insomnia: a nationwide population-based cohort study.J Clin Sleep Med. 2022 May 1;18(5):1335-1342. doi: 10.5664/jcsm.9864. J Clin Sleep Med. 2022. PMID: 34978279 Free PMC article.
-
Tinnitus as a Potential Risk Factor for Uveitis: A 14-Year Nationwide Population-Based Cohort Study in Taiwan.Ocul Immunol Inflamm. 2024 Sep;32(7):1287-1293. doi: 10.1080/09273948.2023.2232444. Epub 2023 Jul 12. Ocul Immunol Inflamm. 2024. PMID: 37437268
-
Tinnitus-associated cognitive and psychological impairments: a comprehensive review meta-analysis.Front Neurosci. 2024 Feb 8;18:1275560. doi: 10.3389/fnins.2024.1275560. eCollection 2024. Front Neurosci. 2024. PMID: 38389785 Free PMC article.
Cited by
-
Teprotumumab-Related Hearing Loss: A Large-Scale Analysis and Review of Voluntarily Reported Patient Complaints to the Food and Drug Administration (FDA).Ophthalmic Plast Reconstr Surg. 2024 Nov-Dec 01;40(6):639-642. doi: 10.1097/IOP.0000000000002668. Epub 2024 May 17. Ophthalmic Plast Reconstr Surg. 2024. PMID: 38771914 Free PMC article.
-
Astrocytes and Tinnitus.Brain Sci. 2024 Nov 29;14(12):1213. doi: 10.3390/brainsci14121213. Brain Sci. 2024. PMID: 39766412 Free PMC article. Review.
-
Increased risk of multisystem comorbidities and disease trajectories following hyperthyroidism: evidence from the 0.5 million UK Biobank population.Endocr Connect. 2025 Apr 23;14(5):e250066. doi: 10.1530/EC-25-0066. Print 2025 May 1. Endocr Connect. 2025. PMID: 40193316 Free PMC article.
-
Tinnitus and Its Comorbidities: A Comprehensive Analysis of Their Relationships.J Clin Med. 2025 Feb 15;14(4):1285. doi: 10.3390/jcm14041285. J Clin Med. 2025. PMID: 40004815 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical